These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17191765)

  • 1. Targeting of lanthanide(III) chelates of DOTA-type glycoconjugates to the hepatic asyaloglycoprotein receptor: cell internalization and animal imaging studies.
    Prata MI; Santos AC; Torres S; André JP; Martins JA; Neves M; García-Martín ML; Rodrigues TB; López-Larrubia P; Cerdán S; Geraldes CF
    Contrast Media Mol Imaging; 2006; 1(6):246-58. PubMed ID: 17191765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lanthanide(III) complexes of DOTA-glycoconjugates: a potential new class of lectin-mediated medical imaging agents.
    André JP; Geraldes CF; Martins JA; Merbach AE; Prata MI; Santos AC; de Lima JJ; Tóth E
    Chemistry; 2004 Nov; 10(22):5804-16. PubMed ID: 15472943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of La(3+) complexes of DOTA/DTPA glycoconjugates with the RCA(120) lectin: a saturation transfer difference NMR spectroscopic study.
    Teixeira JM; Dias DM; Cañada FJ; Martins JA; André JP; Jiménez-Barbero J; Geraldes CF
    J Biol Inorg Chem; 2011 Jun; 16(5):725-34. PubMed ID: 21461972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats.
    Leveille-Webster CR; Rogers J; Arias IM
    Hepatology; 1996 Jun; 23(6):1631-41. PubMed ID: 8675187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugate of arabinogalactan as a potential liver-targeting magnetic resonance imaging contrast agent.
    Xiao Y; Xue R; You T; Li X; Pei F; Wang X; Lei H
    Carbohydr Res; 2014 Aug; 395():9-14. PubMed ID: 24995911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASGPR-Mediated Uptake of Multivalent Glycoconjugates for Drug Delivery in Hepatocytes.
    Monestier M; Charbonnier P; Gateau C; Cuillel M; Robert F; Lebrun C; Mintz E; Renaudet O; Delangle P
    Chembiochem; 2016 Apr; 17(7):590-4. PubMed ID: 26781030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
    Liu X; Han M; Xu J; Geng S; Zhang Y; Ye X; Gou J; Yin T; He H; Tang X
    Int J Pharm; 2017 Mar; 520(1-2):98-110. PubMed ID: 28167263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ga(III) chelates of amphiphilic DOTA-based ligands: synthetic route and in vitro and in vivo studies.
    Fontes A; Prata MI; Geraldes CF; André JP
    Nucl Med Biol; 2011 Apr; 38(3):363-70. PubMed ID: 21492785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gd-complexes of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-1,4,7,10-tetraacetic acid (DOTA) conjugates of tranexamates as a new class of blood-pool magnetic resonance imaging contrast agents.
    Gu S; Kim HK; Lee GH; Kang BS; Chang Y; Kim TJ
    J Med Chem; 2011 Jan; 54(1):143-52. PubMed ID: 21141934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular receptor-binding contrast agent for magnetic resonance imaging of the liver.
    Vera DR; Buonocore MH; Wisner ER; Katzberg RW; Stadalnik RC
    Acad Radiol; 1995 Jun; 2(6):497-506. PubMed ID: 9419597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
    Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
    J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gd(III)-EPTPAC16, a new self-assembling potential liver MRI contrast agent: in vitro characterization and in vivo animal imaging studies.
    Torres S; Prata MI; Santos AC; André JP; Martins JA; Helm L; Tóth E; García-Martín ML; Rodrigues TB; López-Larrubia P; Cerdán S; Geraldes CF
    NMR Biomed; 2008 May; 21(4):322-36. PubMed ID: 17694538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The asialoglycoprotein receptor clears glycoconjugates terminating with sialic acid alpha 2,6GalNAc.
    Park EI; Mi Y; Unverzagt C; Gabius HJ; Baenziger JU
    Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17125-9. PubMed ID: 16286643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kit formulated asialoglycoprotein receptor targeting tracer based on copolymer for liver SPECT imaging.
    Liu C; Guo Z; Zhang P; Song M; Zhao Z; Wu X; Zhang X
    Nucl Med Biol; 2014 Aug; 41(7):587-93. PubMed ID: 24815356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocytosis via galactose receptors in vivo. Ligand size directs uptake by hepatocytes and/or liver macrophages.
    Schlepper-Schäfer J; Hülsmann D; Djovkar A; Meyer HE; Herbertz L; Kolb H; Kolb-Bachofen V
    Exp Cell Res; 1986 Aug; 165(2):494-506. PubMed ID: 3013664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorine-18 labeled galactosyl-neoglycoalbumin for imaging the hepatic asialoglycoprotein receptor.
    Yang W; Mou T; Peng C; Wu Z; Zhang X; Li F; Ma Y
    Bioorg Med Chem; 2009 Nov; 17(21):7510-6. PubMed ID: 19796957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are gadolinium contrast agents suitable for gadolinium neutron capture therapy?
    De Stasio G; Rajesh D; Casalbore P; Daniels MJ; Erhardt RJ; Frazer BH; Wiese LM; Richter KL; Sonderegger BR; Gilbert B; Schaub S; Cannara RJ; Crawford JF; Gilles MK; Tyliszczak T; Fowler JF; Larocca LM; Howard SP; Mercanti D; Mehta MP; Pallini R
    Neurol Res; 2005 Jun; 27(4):387-98. PubMed ID: 15949236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the asialoglycoprotein receptor under hypoxic conditions in primary cultured rat hepatocytes.
    Kwon AH; Inoue T; Ha-Kawa SK
    J Nucl Med; 2005 Feb; 46(2):321-5. PubMed ID: 15695793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR study of ligand release from asialoglycoprotein receptor under solution conditions in early endosomes.
    Onizuka T; Shimizu H; Moriwaki Y; Nakano T; Kanai S; Shimada I; Takahashi H
    FEBS J; 2012 Aug; 279(15):2645-56. PubMed ID: 22613667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lanthanide(III) complexes of bis(phosphonate) monoamide analogues of DOTA: bone-seeking agents for imaging and therapy.
    Vitha T; Kubícek V; Hermann P; Elst LV; Muller RN; Kolar ZI; Wolterbeek HT; Breeman WA; Lukes I; Peters JA
    J Med Chem; 2008 Feb; 51(3):677-83. PubMed ID: 18181563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.